Cargando…
Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study
BACKGROUND: Patients on hemodialysis are at high-risk for complications derived from coronavirus disease 2019 (COVID-19). The present analysis evaluated the impact of a booster vaccine dose and breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on humoral immunity 3...
Ejemplares similares
-
Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum
por: Quiroga, Borja, et al.
Publicado: (2022) -
Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum
por: Quiroga, Borja, et al.
Publicado: (2023) -
Vegetable-Based Diets for Chronic Kidney Disease? It Is Time to Reconsider
por: Cases, Aleix, et al.
Publicado: (2019) -
Protein biomarkers of mood disorders
por: Rodríguez Cerdeira, Carmen, et al.
Publicado: (2017) -
Correction: Choroidal thickness assessment in keratoconus patients treated with cross-linking compared to healthy population
por: Ballesteros-Sánchez, Antonio, et al.
Publicado: (2022)